BALTIMORE (WJZ) — The local race to find a coronavirus cure is getting some help.

Nearly 40 Maryland companies and organizations have secured more than $3 billion to make a vaccine, including Gaithersburg-based Novavax, which was just awarded more than $1.5 billion through “Operation Warp Speed.”


Another Maryland company, Emergent BioSolutions, has signed contracts with big companies like AstraZeneca and Johnson & Johnson.

This comes as the University of Maryland School of Medicine begins the third phase trial of a vaccine.

For the latest information on coronavirus go to the Maryland Health Department’s website or call 211. You can find all of WJZ’s coverage on coronavirus in Maryland here.

CBS Baltimore Staff


Leave a Reply